Literature DB >> 4447386

The inhibition of glucose-6-phosphate dehydrogenase activity by dithranol (anthralin), zinc ions and/or salicylic acid.

W Raab, B Gmeiner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4447386     DOI: 10.1007/BF00560389

Source DB:  PubMed          Journal:  Arch Dermatol Forsch        ISSN: 0003-9187


× No keyword cloud information.
  12 in total

1.  [Conversion of salicylic acid into zinc sal'cylate in ointments & pastes containing both zinc oxide and salicylic acid].

Authors:  E YOUNG; N WEIFFENBACH
Journal:  Ned Tijdschr Geneeskd       Date:  1959-03-21

2.  INHIBITION OF DEHYDROGENASES BY SALICYLATE.

Authors:  W J HINES; M J SMITH
Journal:  Nature       Date:  1964-01-11       Impact factor: 49.962

3.  [Histochemical studies on the behavior of zinc in the skin in psoriasis and other skin diseases].

Authors:  O BRAUN-FALCO; B RATHJENS
Journal:  Dermatol Wochenschr       Date:  1956-08-04

4.  [Biochemical studies on the chemotherapy of psoriasis].

Authors:  H Schaefer
Journal:  Arch Klin Exp Dermatol       Date:  1970

5.  Hospital treatment of psoriasis. A modified anthralin program.

Authors:  E M Farber; D R Harris
Journal:  Arch Dermatol       Date:  1970-04

6.  [Behavior of dithranole (Cignolin) in pastes and solutions and its influencing by salicylic acid].

Authors:  S Lukacs; O Braun-Falco
Journal:  Hautarzt       Date:  1973-07       Impact factor: 0.751

7.  [Inhibition of enzymes by an antipsoriatic substance].

Authors:  H Schaeter
Journal:  Arzneimittelforschung       Date:  1967-10

8.  Conversion of dithranol in ointments and pastes.

Authors:  E Young
Journal:  Dermatologica       Date:  1970

9.  [Glucose-6-phosphate dehydrogenase and topical antipsoriatics. A comparison of anthralin, anthralin-monoacetate, anthralin-diacetate, anthralin-triacetate and 6-hydroxy-2-oxobenzoxathiole (author's transl)].

Authors:  W Raab; H Siber
Journal:  Arch Dermatol Forsch       Date:  1974

10.  Factors affecting the clearance of psoriasis with dithranol (anthralin).

Authors:  S Comaish; J Smith; R H Seville
Journal:  Br J Dermatol       Date:  1971-03       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.